Related Experiment Video
Updated: Apr 29, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Elevated plasma homocysteine level is associated with ischemic stroke in Chinese hypertensive patients
Chang-yi Wang1, Zhong-wei Chen2, Tao Zhang2
1Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, People's Republic of China; Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen, 518054, People's Republic of China.
Insights
Elevated homocysteine levels increase ischemic stroke risk in hypertensive individuals, but not coronary heart disease. This study highlights homocysteine as a significant risk factor for stroke in this population.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Clinical Biochemistry
Background:
- Hyperhomocysteinemia is linked to ischemic stroke (IS) and coronary heart disease (CHD) in the general population.
- The association between homocysteine and cardiovascular events in hypertensive patients is not well-established.
Purpose of the Study:
- To investigate the relationship between plasma total homocysteine (tHcy) levels and the presence of IS and CHD in Chinese hypertensive patients.
Main Methods:
- A cross-sectional study of 5935 Chinese hypertensive patients in Shenzhen.
- Plasma tHcy levels were measured using an enzyme cycle method.
- IS and CHD diagnoses were confirmed through medical records and specialist adjudication.
Main Results:
- Higher plasma tHcy levels were significantly associated with IS in both men and women.
- Increased tHcy showed a dose-dependent association with IS risk (p-trend < 0.001).
- No significant association was found between tHcy and the presence of CHD.
Conclusions:
- Plasma homocysteine is positively associated with ischemic stroke in hypertensive Chinese patients.
- Homocysteine does not appear to be significantly associated with coronary heart disease in this cohort.
Background:
Accumulating data suggest that hyperhomocysteinemia is associated with the risk of ischemic stroke (IS) and coronary heart disease (CHD) in the general population, but the relationship remains unclear in hypertensive patients. We examined the association of total homocysteine (tHcy) with IS and CHD in hypertensive patients.
Methods:
A total of 5935 Chinese hypertensive patients were recruited in a community-based cross-sectional study from 60 communities in Shenzhen, China. Plasma tHcy was quantitatively measured using the enzyme cycle method. Conventional risk factors for IS and CHD were obtained through questionnaire interviews and physical examinations. We included cerebral infarction, embolism and small-vessel disease as IS; and myocardial infarction, angina pectoris, coronary revascularization, and cardiac arrest as CHD. IS and CHD were retrospectively adjudicated by specialists via interviews, hospital records or relevant tests.
Results:
Significantly higher values of tHcy were observed in IS patients than in non-IS controls among both men and women. Greater tHcy level was dose dependently associated with an increased risk of IS presence in women, men and them combined (p-trend: 0.002, 3.8×10(-4) and 0.001). The odds ratios (95% CI) of IS for tHcy ≥30 (vs. <15) μmol/L were 2.84 (1.73-4.34) in men, 4.41 (1.62-9.15) in women, and 2.86 (1.72-4.75) in their combination after adjusting for other main risk factors of IS. We did not find any significant association between tHcy and presence of CHD after the adjustment for covariates.
Conclusions:
Plasma homocysteine level is positively associated with the presence of IS, but not CHD, in Chinese hypertensive patients.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hemorrhagic Stroke l: Introduction
Hypertension II: Pathophysiology
Ischemic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

